Shigematsu Works Co., Ltd. (7980) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

With a fall in Net Sales of -1.05%, the company declared Very Negative results in Jun 25

The company has declared negative results for the last 3 consecutive quarters
INTEREST(HY) At JPY 28.12 MM has Grown at 135.19%
PRE-TAX PROFIT(Q) At JPY 22.5 MM has Fallen at -88.07%
INTEREST COVERAGE RATIO(Q) Lowest at 1,632.7

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

JPY 5,832 Million (Micro Cap)

P/E

7.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.39

Return on Equity

7.69%

Price to Book

0.67

Revenue and Profits:

Net Sales:

2,940 Million

(Quarterly Results - Jun 2025)

Net Profit:

14 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-2.85%

6 Months

-1.51%

1 Year

-2.12%

2 Years

0.9%

3 Years

-8.19%

4 Years

-2.0%

5 Years

-26.01%

Shigematsu Works Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

4.00%

EBIT Growth (5y)

28.31%

EBIT to Interest (avg)

39.80

Debt to EBITDA (avg)

1.40

Net Debt to Equity (avg)

0.42

Sales to Capital Employed (avg)

1.11

Tax Ratio

24.39%

Dividend Payout Ratio

13.66%

Pledged Shares

Institutional Holding

ROCE (avg)

9.16%

ROE (avg)

9.05%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.67

EV to EBIT

8.71

EV to EBITDA

5.26

EV to Capital Employed

0.77

EV to Sales

0.66

PEG Ratio

0.22

Dividend Yield

ROCE (Latest)

8.82%

ROE (Latest)

9.11%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -1.05% vs 13.70% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -89.26% vs 166.60% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,940.10",
          "val2": "2,971.20",
          "chgp": "-1.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "212.80",
          "val2": "312.60",
          "chgp": "-31.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "13.00",
          "val2": "6.10",
          "chgp": "113.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "13.80",
          "val2": "128.50",
          "chgp": "-89.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.40%",
          "val2": "60.60%",
          "chgp": "-5.82%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 8.60% vs 0.93% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 33.64% vs -21.93% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14,112.60",
          "val2": "12,995.40",
          "chgp": "8.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,730.00",
          "val2": "1,311.40",
          "chgp": "31.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "40.90",
          "val2": "21.30",
          "chgp": "92.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "780.60",
          "val2": "584.10",
          "chgp": "33.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "75.80%",
          "val2": "60.40%",
          "chgp": "1.54%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

2,940.10

2,971.20

-1.05%

Operating Profit (PBDIT) excl Other Income

212.80

312.60

-31.93%

Interest

13.00

6.10

113.11%

Exceptional Items

0.00

Consolidate Net Profit

13.80

128.50

-89.26%

Operating Profit Margin (Excl OI)

2.40%

60.60%

-5.82%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is -1.05% vs 13.70% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -89.26% vs 166.60% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

14,112.60

12,995.40

8.60%

Operating Profit (PBDIT) excl Other Income

1,730.00

1,311.40

31.92%

Interest

40.90

21.30

92.02%

Exceptional Items

0.00

Consolidate Net Profit

780.60

584.10

33.64%

Operating Profit Margin (Excl OI)

75.80%

60.40%

1.54%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 8.60% vs 0.93% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 33.64% vs -21.93% in Mar 2024

All Annual Results

Company CV

About Shigematsu Works Co., Ltd.

Shigematsu Works Co., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available